NCT06625671: A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 148 planned
- Started
- 4 Oct 2024
- Primary completion
- 30 Jun 2027
- Arms
- Dose Level 1, Dose Level 2, Dose Level 3, Dose Level 4, Dose Level 5
- Results
- None posted
- 3 Oct 2024: Trial registered
- 4 Oct 2024: Trial started